2012-09-18 08:04:50 - New Pharmaceuticals market report from Global Markets Direct: "Autoimmune Disorders - Pipeline Review, H2 2012"

Global Markets Direct's, 'Autoimmune Disorders - Pipeline Review, H2 2012', provides an overview of the Autoimmune Disorders therapeutic pipeline. This report provides information on the therapeutic development for Autoimmune Disorders, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Autoimmune Disorders. 'Autoimmune Disorders - Pipeline Review, H2 2012' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.


Full Report Details at
- www.fastmr.com/prod/463883_autoimmune_disorders_pipeline_review_ ..


Note*: Certain sections in the report may be removed or altered based

on the availability and relevance of data for the indicated disease.

Scope

* A snapshot of the global therapeutic scenario for Autoimmune Disorders.
* A review of the Autoimmune Disorders products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
* Coverage of products based on various stages of development ranging from discovery till registration stages.
* A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
* Coverage of the Autoimmune Disorders pipeline on the basis of route of administration and molecule type.
* Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress.
* Key discontinued pipeline projects.
* Latest news and deals relating to the products.

Reasons to buy

* Identify and understand important and diverse types of therapeutics under development for Autoimmune Disorders.
* Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
* Plan mergers and acquisitions effectively by identifying players with the most promising pipeline.
* Devise corrective measures for pipeline projects by understanding Autoimmune Disorders pipeline depth and focus of Autoimmune Disorders therapeutics.
* Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
* Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Keywords

Autoimmune Disorders Therapeutic Products under Development, Key Players in Autoimmune Disorders Therapeutics, Autoimmune Disorders Pipeline Overview, Autoimmune Disorders Pipeline, Autoimmune Disorders Pipeline Assessment

Partial Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Autoimmune Disorders Overview
Therapeutics Development
An Overview of Pipeline Products for Autoimmune Disorders
Autoimmune Disorders Therapeutics under Development by Companies
Autoimmune Disorders Therapeutics under Investigation by Universities/Institutes
Late Stage Products
Comparative Analysis
Mid Clinical Stage Products
Comparative Analysis
Early Clinical Stage Products
Comparative Analysis
Discovery and Pre-Clinical Stage Products
Comparative Analysis
Autoimmune Disorders Therapeutics - Products under Development by Companies
Autoimmune Disorders Therapeutics - Products under Investigation by Universities/Institutes
Companies Involved in Autoimmune Disorders Therapeutics Development
Alcon, Inc.
Bristol-Myers Squibb Company
Genzyme Corporation
Johnson & Johnson
F. Hoffmann-La Roche Ltd.
Kyowa Hakko Kirin Co., Ltd.
Abbott Laboratories
Biogen Idec Inc.
Valeant Pharmaceuticals International
Amgen Inc.
Antares Pharma, Inc.
Sanofi-Aventis
AstraZeneca PLC
Eli Lilly and Company
GlaxoSmithKline plc
Genentech, Inc.
Inovio Biomedical Corporation
MedImmune LLC
Isis Pharmaceuticals, Inc.
Biotest AG
Merck & Co., Inc.
Stiefel Laboratories, Inc.
Santen Pharmaceutical Co., Ltd.
Ablynx
AbGenomics International, Inc.
Emergent BioSolutions Inc.
Novo Nordisk A/S
Gamida Cell Ltd.
Albany Molecular Research, Inc.
Plexxikon Inc.
XenoPort, Inc.
BioLineRx, Ltd.
ApoPharma
FibroGen, Inc.
arGentis Pharmaceuticals, LLC
Reliance Life Sciences Pvt. Ltd.
MediGene AG
Celltrion, Inc.
Apitope International NV
Nycomed International Management GmbH
TiGenix NV
Pacira Pharmaceuticals, Inc.
Novartis AG
Actelion Ltd
Astellas Pharma Inc.
Biocon Limited
BioMarin Pharmaceutical Inc.
Cephalon, Inc.
Chugai Pharmaceutical Co. Ltd
Cipla Ltd.
Daewoong Pharmaceutical Co., Ltd.
Dr. Reddy's Laboratories Limited
Eisai Co., Ltd.
Elan Corporation, plc
Gedeon Richter Plc.
Glenmark Pharmaceuticals Ltd.
Human Genome Sciences, Inc.
Japan Tobacco Inc.
Kissei Pharmaceutical Co., Ltd.

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=463883&dt=t

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at www.fastmr.com/catalog/publishers.aspx?pubid=1033

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.